Carl G. Feng - Infectious Diseases

Author Information

Carl G. Feng is a prominent researcher affiliated with the Guangdong Key Laboratory of Emerging Infectious Diseases at Shenzhen Third People's Hospital, which is part of Guangdong Medical University in Shenzhen, Guangdong, China. His research primarily focuses on immune responses and vaccine development related to infectious diseases, with a particular emphasis on tuberculosis and viral infections such as COVID-19.

Research Contributions

Carl G. Feng has made significant contributions to the field of infectious diseases, as shown by his extensive publication record. His research includes high-impact studies on immune profiling, vaccine efficacy, and the immune system's response to infections like SARS-CoV-2 and Mycobacterium tuberculosis. Noteworthy papers include investigations into interferon responses post-COVID-19 vaccination, single-cell immune profiling in tuberculosis, and potential vaccine strategies providing sterilizing immunity against SARS-CoV-2. His work often employs cutting-edge technologies like single-cell transcriptomics and transcriptomic profiling to unravel the complexities of immune responses.

Aliases

Carl G. Feng is also known as Carl Feng, Carl G Feng, C G Feng, and C. G. Feng. These aliases are commonly used in academic publications and databases.

Publication and Citation Metrics

Metric	Value
Total Citation Count	10,203
h-index	51
Paper Count	133

Publications:

High temporal resolution systems profiling reveals distinct patterns of interferon response after Covid-19 mRNA vaccination and SARS-CoV2 infection

DOI: 10.1101/2021.12.12.472257

Year: 2022

Corrigendum to ‘single-cell transcriptomics of blood reveals a natural killer cell subset depletion in tuberculosis’ [EBioMedicine 53 (2020) 102686]

DOI: 10.1016/j.ebiom.2022.103905

Year: 2022

Single-cell immune profiling reveals functional diversity of T cells in tuberculous pleural effusion.

DOI: 10.1084/jem.20211777

Year: 2022

Pidotimod increases inflammation in wounded zebrafish embryos.

DOI: 10.1016/j.fsi.2021.12.013

Year: 2021

TCR Affinity Controls the Dynamics but Not the Functional Specification of the Antimycobacterial CD4+ T Cell Response

DOI: 10.4049/jimmunol.2001271

Year: 2021

Tissue‐resident regulatory T cells accumulate at human barrier lymphoid organs

DOI: 10.1111/imcb.12481

Year: 2021

Targeting Aryl Hydrocarbon Receptor Signaling Enhances Type I Interferon-Independent Resistance to Herpes Simplex Virus

DOI: 10.1128/Spectrum.00473-21

Year: 2021

A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection

DOI: 10.1038/s41541-021-00406-4

Year: 2021

Transcriptomic Profiling Identifies Neutrophil-Specific Upregulation of Cystatin F as a Marker of Acute Inflammation in Humans

DOI: 10.3389/fimmu.2021.634119

Year: 2021

Mucosal vaccination with CysVac2/Advax induces Th17 lung-resident CD4+ T cells and interleukin-17-dependant protection against Mycobacterium tuberculosis infection

DOI: 10.1101/2020.02.25.964312

Year: 2020

What is an Apicoplast?

How Long Can Respiratory Droplets Remain Infectious?

What Are Some Common Diseases Spread by Direct Contact?

What Role Do ID Specialists Play in Public Health?

What are Imaging Studies?

What Are the Limitations of Throat Swabs?

What is the Future of Vaccinations?

What is Epigenetics?

What are Adenoviruses?

How Does Viral Interference Occur?

Partnered Content Networks

Relevant Topics